Lightlake Therapeutics Inc. (LLTP) is a publicly traded company in the Unknown sector. Across all available filings, 1 corporate insiders have executed 14 transactions totaling $11.9K, demonstrating a bearish sentiment with -$11.9K in net insider flow. The most recent transaction on Jan 21, 2015 involved a transaction of 1,500 shares valued at $5.9K.
No significant insider buying has been recorded for LLTP in the recent period.
No significant insider selling has been recorded for LLTP in the recent period.
Based on recent SEC filings, insider sentiment for LLTP is bearish with an Insider Alignment Score of 0/100 and a net flow of -$11.9K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Lightlake Therapeutics Inc. (LLTP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 1 insiders are actively trading LLTP stock, having executed 14 transactions in the past 90 days. The most active insider is Michael Sinclair (Executive), who has made 14 transactions totaling $70.7K.
Get notified when executives and directors at LLTP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 21, 2015 | Sinclair Michael | Executive | Award | 1,500 | $3.94 | $5.9K | |
| Jan 21, 2015 | Sinclair Michael | Executive | Award | 1,500 | $3.94 | $5.9K | |
| Jan 20, 2015 | Sinclair Michael | Executive | Award | 1,600 | $3.69 | $5.9K | |
| Jan 20, 2015 | Sinclair Michael | Executive | Award | 1,600 | $3.69 | $5.9K | |
| Jan 16, 2015 | Sinclair Michael | Executive | Award | 1,700 | $3.69 | $6.3K | |
| Jan 16, 2015 | Sinclair Michael | Executive | Award | 1,700 | $3.69 | $6.3K | |
| Jan 15, 2015 | Sinclair Michael | Executive | Sale | 1,700 | $3.50 | $6.0K | |
| Jan 15, 2015 | Sinclair Michael | Executive | Sale | 1,700 | $3.50 | $6.0K | |
| Oct 21, 2013 | Sinclair Michael | Executive | Award | 20,000 | $N/A | $0 | |
| May 24, 2012 | Sinclair Michael | Executive | Award | 10,000 | $0.06 | $600 | |
| May 22, 2012 | Sinclair Michael | Executive | Award | 100,000 | $0.06 | $6.0K | |
| May 21, 2012 | Sinclair Michael | Executive | Award | 50,000 | $0.08 | $4.0K | |
| May 18, 2012 | Sinclair Michael | Executive | Award | 150,000 | $0.08 | $12.0K | |
| Jan 10, 2012 | Sinclair Michael | Executive | Award | 5,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 12 | $58.8K | 83.2% |
Sale(S) | 2 | $11.9K | 16.8% |
Insider selling pressure at Lightlake Therapeutics Inc. has increased, with 1 insiders executing 14 transactions across all time. Total sales of $11.9K significantly outpace purchases of $0, resulting in a net outflow of $11.9K. This selling activity appears largely discretionary, which may warrant closer attention from investors.